Xue, Yonger https://orcid.org/0000-0002-6022-2487
Hou, Xucheng https://orcid.org/0000-0001-7833-8704
Zhong, Yichen https://orcid.org/0000-0003-3652-1257
Zhang, Yuebao https://orcid.org/0009-0000-7883-1937
Du, Shi
Kang, Diana D.
Wang, Leiming
Wang, Chang https://orcid.org/0009-0005-1630-9453
Li, Haoyuan
Wang, Siyu
Liu, Zhengwei https://orcid.org/0009-0003-5105-6709
Tian, Meng https://orcid.org/0000-0001-7719-9896
Guo, Kaiyuan https://orcid.org/0009-0001-0621-9543
Cao, Dinglingge
Deng, Binbin
McComb, David W. https://orcid.org/0000-0003-3763-9652
Purisic, Eric
Dai, Jinye
Hamon, Pauline https://orcid.org/0000-0002-6776-1635
Brown, Brian D. https://orcid.org/0000-0002-3670-8778
Tsankova, Nadejda M.
Merad, Miriam https://orcid.org/0000-0002-4481-7827
Irvine, Darrell J. https://orcid.org/0000-0002-8637-1405
Weiss, Ron https://orcid.org/0000-0003-0396-2443
Dong, Yizhou https://orcid.org/0000-0001-5786-0659
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM119679, R35GM144117)
Article History
Received: 12 August 2024
Accepted: 13 February 2025
First Online: 4 March 2025
Competing interests
: Y.D. is a scientific advisor in Arbor Biotechnologies. Y.D. is a co-founder and holds equity in Immunanoengineering Therapeutics. D.J.I. and R.W. are scientific advisory board members and hold equity in Strand Therapeutics. The remaining authors declare no competing interests.